MedPath

Radiotherapy for pathological stage Ia and IIa (Upper) Hodgkin's disease

Completed
Conditions
Cancer
ymphoma (Hodgkin's)
Lymphoma (Hodgkin's)
Registration Number
ISRCTN98387311
Lead Sponsor
Cancer Research UK (CRUK) (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Pathological stage Ia and IIa (upper) Hodgkin's disease
2. Aged 15 to 65 years

Exclusion Criteria

Patients with mediastinal disease will not in general be eligible for local radiotherapy alone

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ot provided at time of registration
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath